These results suggest that loss of Golga7 diminishes NrasG12D‐mediated signaling pathways for cell growth and proliferation, and therefore slows the progression of NrasG12D‐driven CMML‐like MPN(Figure 2F). Here, GOLGA7 is linked to myeloproliferative disorder.